New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
09:58 EDTSPEXSpherix, Fullife Healthcare sign supply and license agreement
Spherix Incorporated and Fullife Healthcare announced the signing of a supply and license agreement for the use of D-tagatose in nutraceutical products in India. Under the terms of the agreement, Spherix has granted Fullife an exclusive, royalty-bearing license in India for use of Spherix's clinical data and proprietary know-how to support marketing and dosing of the D-tagatose that Spherix will also be supplying. The D-tagatose will be used in food or cosmetic products that may provide health benefits in return for a fixed royalty on gross sales. Spherix will provide bulk D-Tagatose to Fullife and Fullife will be responsible for all testing and development of products containing D-Tagatose for sale in India. Financial terms of the agreement were not disclosed.
News For SPEX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
06:27 EDTSPEXSpherix provides litigation update
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use